Combined use of aspirin and warfarin in primary prevention of ischemic heart disease in men at high risk
- 23 February 1995
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 75 (6) , 23B-26B
- https://doi.org/10.1016/0002-9149(95)80006-e
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.Circulation, 1994
- A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve ReplacementNew England Journal of Medicine, 1993
- Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic eventsThe Lancet, 1991
- Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery diseaseThe Lancet, 1990
- Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin.BMJ, 1989
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: Danger of aspirin compared with dipyridamoleThe American Journal of Cardiology, 1983
- Bleeding during acetylsalicylic acid and anticoagulant therapy in patients with reduced platelet reactivity after aortic valve replacementAmerican Heart Journal, 1980